FP7
NEWMEDS
Novel Methods leading to New Medications in Depression and Schizophrenia
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 66 months
- Total cost
- EUR 24,849,675
- EU contribution
- EUR 8,986,216
- Participants
- 18 from 11 countries
- Topic
- FP7_IMI-JU-01-2008-10
- Grant agreement
- 115008
Coordinated by H. Lundbeck As (DKDenmark).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| H. Lundbeck As | DKDenmark | Coordinator | Not stated | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | Not stated | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Abbvie Deutschland GmbH & Co KG | DEGermany | Participant | Not stated | PIC (1.00) |
| Gabo:mi Gesellschaft Fur Ablauforganisation:milliarium Mbh & Co KG | DEGermany | Participant | EUR 564,810 | PIC (1.00) |
| Zentralinstitut Fuer Seelische Gesundheit | DEGermany | Participant | EUR 1,149,873 | PIC (1.00) |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | ESSpain | Participant | EUR 682,467 | PIC (1.00) |
| Orion OYJ | FIFinland | Participant | Not stated | PIC (1.00) |
| Institut de Recherches Servier | FRFrance | Participant | Not stated | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 2,592,966 | known name (0.95) |
| Psynova Neurotech Ltd | GBUnited Kingdom | Participant | EUR 40,226 | PIC (1.00) |
| The Chancellor Masters and Scholars of the University of Cambridge | GBUnited Kingdom | Participant | EUR 1,333,476 | known name (0.95) |
| The University of Manchester | GBUnited Kingdom | Participant | EUR 604,471 | known name (0.95) |
| Bar Ilan University | ILIsrael | Participant | EUR 355,999 | PIC (1.00) |
| Islensk Erfdagreining Ehf | ISIceland | Participant | EUR 869,378 | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Karolinska Institutet | SESweden | Participant | EUR 792,550 | known name (0.95) |
Changes of the consortium
First seen on with 18 participants from 11 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.